NCT06079541View on ClinicalTrials.gov

Phase 1 Clinical Study of JMKX003142 Tablets

PHASE1UnknownINTERVENTIONAL

Enrollment

106

Participants

Timeline

Start Date

July 6, 2023

Primary Completion Date

July 31, 2024

Study Completion Date

March 30, 2025

Conditions

Safety and Tolerability

Interventions

DRUG

JMKX003142 will be administered orally

oral once

DRUG

JMKX003142 will be administered orally

oral once

DRUG

JMKX003142 will be administered orally

oral once

DRUG

Placebo in Cohorts 1 to 7

oral once

DRUG

Placebo in 3 Cohorts

oral once

Trial Locations (1)

Unknown

RECRUITING

Zhongshan Hospital, Fudan University, Shanghai

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Zhejiang Hangyu Pharmaceutical Co., Ltd.

INDUSTRY

lead

Jemincare

INDUSTRY

NCT06079541 - Phase 1 Clinical Study of JMKX003142 Tablets | Biotech Hunter | Biotech Hunter